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Abstract 21 
We investigated the effects of endogenous inducible (iNOS) and neuronal nitric oxide synthase 22 
(nNOS) on recovery from intestinal mucosal atrophy caused by fasting-induced apoptosis and 23 
decreased cell proliferation during refeeding in rats. Rats were divided into five groups, one of which 24 
was fed ad libitum, and four of which underwent 72 h of fasting, followed by refeeding for 0, 6, 24, 25 
and 48 h, respectively. iNOS and nNOS mRNA and protein levels in jejunal tissues were measured, 26 
and mucosal height was histologically evaluated. Apoptotic indices, interferon-γ (IFN-γ) 27 
transcription levels, nitrite levels (as a measure of nitric oxide [NO] production), 28 
8-hydroxydeoxyguanosine formation (indicating reactive oxygen species [ROS] levels), crypt cell 29 
proliferation, and the motility indices (MI) were also estimated. Associations between mucosal 30 
height and NOS protein levels were determined using Spearman’s rank correlation test. Notably, we 31 
observed significant increases in mucosal height and in nNOS mRNA and protein expression as 32 
refeeding time increased. Indeed, there was a significant positive correlation between nNOS protein 33 
level and mucosal height during the 48-h refeeding period (r = 0.725, P < 0.01). Conversely, iNOS 34 
mRNA and protein expression decreased according to refeeding time, with a significant negative 35 
correlation between iNOS protein level and mucosal height being recorded during the 48-h refeeding 36 
period (r = -0.898, P < 0.01). We also noted a significant negative correlation between jejunal nNOS 37 
and iNOS protein concentrations over this same period (r = -0.734, P < 0.01). Refeeding also 38 
restored the decreased jejunal MI caused by fasting. Our finding suggests that refeeding likely 39 
repairs fasting-induced jejunal atrophy by suppressing iNOS expression and subsequently inhibiting 40 
NO, ROS, and IFN-γ as apoptosis mediators, and by promoting nNOS production and inducing crypt 41 
cell proliferation via mechanical stimulation.  42 
 43 
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 46 
Impact Statement 47 
Besides providing new data confirming the involvement of iNOS and nNOS in intestinal mucosal 48 
atrophy caused by fasting, this study details their expression and function during recovery from this 49 
condition following refeeding. We demonstrate a significant negative correlation between iNOS and 50 
nNOS levels during refeeding, and associate this with cell proliferation and apoptosis in crypts and 51 
villi. These novel findings elucidate the relationship between these NOS isoforms and its impact on 52 
recovery from intestinal injury. A mechanism is proposed comprising the up-regulation of nNOS 53 
activity by mechanical stimulation due to the presence of food in the intestine, restricting 54 
iNOS-associated apoptosis and promoting cell proliferation and gut motility. Our investigation sheds 55 
light on the molecular basis behind the repercussions of total parenteral nutrition on intestinal 56 
mucosal integrity and more importantly, the beneficial effects of early enteral feeding. 57 
 58 
  59 
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Introduction 60 
Prolonged fasting impairs intestinal physiology and causes intestinal barrier dysfunction, including 61 
increased epithelial permeability and compromised tight junctions, leading to bacterial translocation, 62 
particularly in patients receiving a prolonged course of total parenteral nutrition (TPN).1,2 Many 63 
surgeons involved in nutrition support therapy often observe the beneficial effects of early enteral 64 
feeding as opposed to protracted TPN, particularly regarding intestinal barrier functions and 65 
subsequent septic complications.3-5 Early enteral feeding, therefore, represents a potentially 66 
important therapeutic intervention for the maintenance of intestinal mucosal homeostasis and 67 
integrity. 68 
Under pathological conditions such as intestinal starvation during TPN, increased apoptosis and 69 
decreased cell proliferation are observed in the intestinal epithelium.6-8 Using histomorphometric 70 
analysis, we previously demonstrated comparable pathological changes in rats fasted for 72 h, 71 
comprising heightened apoptosis and reduced cell proliferation, predominantly in villi and crypts,9 72 
suggesting the involvement of a similar mechanism effecting such changes. In addition, this previous 73 
work attributed fasting-induced rat intestinal atrophy to jejunal inducible nitric oxide (NO) synthase 74 
(iNOS)-mediated apoptosis. Decreased neuronal NOS (nNOS) expression was also evident in rat 75 
intestine during fasting, suggesting roles for both nNOS and iNOS in the regulation of 76 
fasting-induced mucosal atrophy.  77 
NO is a weak radical generated from L-arginine by the three NOS isoforms nNOS, iNOS, and 78 
endothelial NOS. NO is important in protection against bowel injury10,11 and iNOS plays a key role 79 
in this pathology. For instance, rat small intestines with histological abnormalities demonstrate 80 
increased iNOS expression.9,12 nNOS is the predominant isoform in the intestine, and its activity is 81 
inversely correlated with the extent of tissue injury.13 82 
Previous investigations using animal models have suggested that nNOS and iNOS are key in the 83 
development and progression of post-inflammatory functional gastrointestinal disorders,14 84 
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ischemia-reperfusion injury (IRI), acute rejection (AR) in intestinal transplantation,15 and necrotizing 85 
enterocolitis (NEC).12 The pathologies described in each of these studies involved increased iNOS 86 
and decreased nNOS levels. 87 
However, the effect of iNOS and nNOS on recovery by refeeding from fasting-induced mucosal 88 
atrophy remains unclear. Therefore, a fundamental understanding of the underlying mechanisms 89 
operating during these processes is needed. The objective of the present study was to investigate the 90 
manner in which iNOS and nNOS affect rat intestinal healing associated with refeeding after 91 
mucosal atrophy caused by fasting-induced apoptosis and suppressed cell proliferation. 92 
 93 
Materials and Methods 94 
Animals and experimental design 95 
The current experimental protocol and design were approved by the Institutional Animal Care and 96 
Use Committee of the Life Science Center of Josai University. Nine-week-old male Wistar rats were 97 
purchased from SLC (Shizuoka, Japan) and housed individually in wire-bottom cages in a room 98 
illuminated from 7:00 a.m. to 7:00 p.m. (12:12-h light:dark cycle). Animals were allowed free access 99 
to deionized water and standard rat chow (CE-2; CLEA, Tokyo, Japan) until the study began. At 10 100 
weeks of age, 35 rats were randomly divided into five groups. Four groups were fasted for 72 h, and 101 
refed for 0 (i.e. 72-h fasted), 6, 24, or 48 h. The remaining group was given ad libitum access to food 102 
as a normally fed control. Rats were weighed daily. Furthermore, jejunal peristalsis was measured in 103 
three rats to calculate the motility index (MI). 104 
Collection of intestinal mucosa 105 
After refeeding, rats were anesthetized and euthanized by exsanguination. The entire small intestine 106 
was carefully removed and placed on ice. Ten centimetres was removed from the oral (duodenum) 107 
side, and the remainder of the intestine was divided into two segments: proximal (jejunum) and distal 108 
(ileum). Jejunum segments 3 to 5 cm distal to the duodenum were used in analyses.16 Samples 109 
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approximately 3 cm in length were fixed in 10% neutral buffered formalin for measurement of 110 
mucosal height and immunohistochemistry. The remaining segments were snap-frozen in liquid 111 
nitrogen and stored at -80°C. 112 
Histopathological analysis of mucosal height, apoptotic index (AI), and cell proliferation 113 
Tissue samples fixed in 10% neutral buffered formalin were embedded in paraffin and sectioned, 114 
before being stained with hematoxylin and eosin (H&E). Mucosal height (villous height plus crypt 115 
depth) was measured using a microscope (BX41; Olympus, Tokyo, Japan) and a digital camera 116 
system (Penguin 150CL; Pixera, San Jose, CA, USA). Mucosal height was measured for at least 30 117 
villi per animal. 118 
To measure enterocyte apoptosis in the jejunum, the AI was calculated by conventional light 119 
microscopy of H&E-stained specimens, following the methods of Dahly et al. and Ito et al.6,9 120 
Terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) staining of apoptotic cells 121 
is easy to interpret for all images; however, because of its nonspecific staining, representative 122 
apoptotic changes were utilised for the analysis of AI. In brief, jejunal sections as used above for 123 
histopathological analysis were examined in a blinded manner for the typical attributes of apoptotic 124 
cells. Fifty villus-crypt columns were assessed per rat. For each column, the number and position of 125 
apoptotic cells and the total number of cells were recorded. To measure the effects of fasting and 126 
refeeding on apoptosis, the average number of apoptotic cells in villi and crypts and the AI were 127 
determined. To ascertain the principal sites of apoptosis along the villi and crypts, AI distribution 128 
profiles were generated based on group means, in which cell position was plotted against the AI for 129 
that position. AI, in this case, was defined as the total number of apoptotic cells at each position 130 
expressed as a percentage of the total number of cells counted at that position. Position 1 was set as 131 
the cell at the crypt-villus junction, and that at the base of the crypt column, for villus and crypt data, 132 
respectively. 133 
To assess cell proliferation in the crypt, conventional light microscopy of specimens 134 
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immunohistochemically stained for 5-bromo-2′-deoxyuridine (5-BrdU) was used to calculate the cell 135 
proliferation index.17 Rats were given intraperitoneal injections of 100 mg/kg 5-BrdU before 136 
euthanasia. After paraffin embedding and sectioning, tissue sections were dewaxed and immersed in 137 
3% hydrogen peroxide-methanol solution before being washed with phosphate-buffered saline (PBS) 138 
and denatured in 2 N hydrochloric acid. Following further PBS washing, the specimens were 139 
immersed in 0.1 M boric acid buffer (pH 8.5), incubated with 20 µg/mL proteinase K at 37°C and 140 
then the reaction was terminated with PBS containing bovine serum albumin. The sections were then 141 
incubated with mouse anti-5-BrdU monoclonal antibody (1:50; Chemicon International, Billerica, 142 
MA, USA), with the exception of control samples, for which the primary antibody was omitted. A 143 
biotinylated goat anti-mouse IgG secondary antibody (1:200; Vector Laboratories, Burlingame, CA, 144 
USA) was subsequently applied. Sections were then treated with a VECTASTAIN Elite ABC Kit 145 
(Vector Laboratories), and staining was visualized by colour development following addition of 146 
diaminobenzidine. Finally, the sections were counterstained with hematoxylin and examined under a 147 
light microscope with a digital camera system. The number of labelled cells in at least 10 148 
well-orientated longitudinal crypts was determined for each rat. Results are expressed as the number 149 
of 5-BrdU-labelled cells per crypt. 150 
Immunohistochemical assessment of iNOS and nNOS expression 151 
Immunohistochemical staining was performed with a rabbit anti-iNOS polyclonal antibody and a 152 
mouse anti-nNOS monoclonal antibody.18 The specimens were dewaxed and treated for antigen 153 
retrieval by boiling in 10 mM citrate buffer (pH 6.0).19 After being washed with PBS, they were then 154 
exposed to 6% hydrogen peroxide, and nonspecific binding was blocked with 20% goat serum in 155 
PBS. Specimens were subsequently incubated with one of the primary antibodies (1:100; BD 156 
Transduction Laboratories, Lexington, KY, USA), except for control sections, for which no primary 157 
antibody was used. Biotinylated goat anti-rabbit or goat anti-mouse IgG secondary antibodies (1:200; 158 
Vector Laboratories) were then added. The sections were treated with a VECTASTAIN Elite ABC 159 
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Kit, and antibody binding was detected by colour development after addition of diaminobenzidine. 160 
Finally, sections were counterstained with hematoxylin, and examined under a light microscope with 161 
a digital camera system. 162 
Five clearly dyed sections were chosen randomly for each rat, and five random fields for each 163 
section were assessed (at 40× magnification). The presence of iNOS and nNOS was 164 
semi-quantitatively measured based on average optical density using a digital camera and ImageJ 165 
software (National Institutes of Health, Bethesda, MD, USA; http://imagej.nih.gov/ij/).12 166 
Jejunal nitrite concentrations 167 
Nitrite concentrations in the jejunum were measured using a dedicated high-performance liquid 168 
chromatography (HPLC) system (ENO-20; EiCom, Kyoto, Japan). Frozen jejunal segments were 169 
deproteinised by homogenization with an equal volume of methanol and centrifugation at 12,000×g 170 
for 5 min at 4°C.20 The samples were then applied to the HPLC system. Nitrite and nitrate were 171 
separated using a reverse-phase column (NO-PAK; EiCom), after which, nitrate was reduced to 172 
nitrite in a reduction column packed with copperised cadmium (NO-RED; EiCom). These nitrites 173 
were then mixed with Griess reagent in a reaction coil, and the change in absorbance was monitored 174 
at 540 nm. 175 
Analysis of iNOS, nNOS, and interferon (IFN)-γ mRNA expression by reverse 176 
transcription-polymerase chain reaction (RT-PCR) 177 
Total RNA was purified using RNAiso reagent (TaKaRa Bio, Kusatsu, Japan) and subjected to 178 
RT-PCR using an RNA PCR Kit (AMV) Version 3.0 (TaKaRa Bio), as follows: 42°C for 30 min, 179 
99°C for 5 min, and 5°C for 5 min for reverse transcription; then 30 cycles of 94°C for 30 s, 60°C for 180 
30 s, and 72°C for 1 min for PCR. The following primer pairs (synthesized by TaKaRa Bio) were 181 
used: iNOS forward, 5′-CTCACTGTGGCTGTGGTCACCTA-3′; iNOS reverse, 182 
5′-GGGTCTTCGGGCTTCAGGTTA-3′ (product size: 101 bp, TaKaRa Bio ID: RA008296); nNOS 183 
forward, 5′-TCAAAGCCATCCAGCGCATA-3′; nNOS reverse, 184 
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5′-GCGGTTGGTCACTTCATACGTTC-3′ (146 bp, RA022317); IFN-γ forward, 185 
5′-AGGCCATCAGCAACAACATAAGTG-3′; IFN-γ reverse, 186 
5′-GACAGCTTTGTGCTGGATCTGTG-3′ (140 bp, RA021293). Expression of target mRNAs was 187 
normalised to that of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which was measured 188 
using the following primers: GAPDH forward, 5′-GGCACAGTCAAGGCTGAGAATG-3′; GAPDH 189 
reverse, 5′-ATGGTGGTGAAGACGCCAGTA-3′ (143 bp, RA015380). An aliquot of each PCR was 190 
electrophoresed on a 2% agarose gel in Tris-borate-EDTA buffer, and DNA bands were visualized 191 
using ethidium bromide staining. PCR product intensity was measured using the GeneGenius 192 
Bioimaging System (Syngene, Cambridge, UK). 193 
DNA oxidation analysis 194 
Oxidative stress in the jejunum was evaluated by quantifying 8-hydroxydeoxyguanosine (8-OHdG) 195 
present in DNA.21 This molecule results from DNA oxidation and is produced by enzymatic cleavage 196 
after 8-hydroxylation of a guanine base. It is thought to be a marker of oxidative DNA damage 197 
reflecting the DNA repair rate.22 Jejunal DNA was purified using a DNA Extractor TIS Kit (Wako, 198 
Osaka, Japan).23 DNA samples were hydrolysed to nucleosides by sequential incubation with 6 U 199 
nuclease P1 (Wako) and 2 U alkaline phosphatase (Wako). Hydrolysates were filtered through 200 
Vivaspin 500 centrifugal concentrators with a molecular weight cut-off of 10,000 (Sartorius Stedim 201 
Biotech, Gottingen, Germany), and levels of 8-OHdG in the filtered samples were determined with 202 
an enzyme-linked immunosorbent assay kit (ELISA; Japan Institute for the Control of Aging, 203 
Shizuoka, Japan). 204 
Jejunal motility 205 
Nine-week-old male Wistar rats were operated upon during pentobarbital anaesthesia (35 mg/kg 206 
Somnopentyl, administered intraperitoneally). Through a midline skin incision, a miniature strain 207 
gauge force transducer (FT-04IS; Star Medical, Tokyo, Japan) developed for in vivo small intestine 208 
motility studies of small animals was sutured around the circumference of the serosal surface of the 209 
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jejunum, 4 to 5 cm distal to the ligament of Treitz.24 In addition, a telemeter (IMT-101T; Star 210 
Medical) was sutured in the abdominal cavity of the left lower abdomen quadrant. After 10 days to 211 
recover from the operation, rats were used in the experiment. Each rat was placed in a plastic case on 212 
a receiver (IMT-10RA; Star Medical), the signals from which were relayed to a computer through a 213 
PowerLab 4/25 data acquisition system (ADInstruments, Tokyo, Japan). Rats were fasted for 3 days 214 
after ad libitum access to standard rat chow, before being refed for 3 days. Fasting and refeeding 215 
started at 9:00 a.m. 216 
The recording of jejunal contractions was adjusted using software (Chart 5; ADInstruments) to 217 
correct for movements unrelated to intestinal motility. The MI, calculated using these modified 218 
measurements, was defined as the area under the contraction curves in each 30 min recording, and is 219 
expressed as a proportion of the mean MI recorded during the 24-h ad libitum feeding period prior to 220 
fasting.  221 
Statistical analysis 222 
Statistical analyses were performed using SPSS Version 22 for Windows (IBM, Armonk, NY, USA). 223 
All values are expressed as means ± SE. One-way analysis of variance followed by Tukey’s test was 224 
used to determine statistical differences between treatment groups. P-values < 0.05 were considered 225 
statistically significant. Associations between mucosal height and NOS protein levels were analysed 226 
using the Spearman’s rank correlation test. 227 
 228 
Results 229 
Evaluation of intestinal mucosal height and nNOS and iNOS protein expression in fasted and 230 
refed rats 231 
Table 1 shows body weights, mucosal heights, and nNOS and iNOS protein expression of rats in 232 
each treatment group. Rats fasted for 72 h (0 h refeeding) lost approximately 25% (P < 0.01) of their 233 
body weight compared with control rats fed ad libitum. After refeeding, gradual increases in body 234 
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weight were observed. Although rats fasted for 72 h exhibited a greater degree of jejunal mucosal 235 
atrophy than those fed ad libitum, significant recovery (P < 0.01) of mucosal height was observed 236 
after 24 and 48 h of refeeding, compared with 0 h. 237 
Staining of nNOS protein was mainly seen in the myenteric plexus and nerve fibres of the jejunal 238 
muscle layer (Figure 1). As shown in Table 1, quantitative measurement using average optical 239 
densities revealed that nNOS expression decreased after fasting (0 h refeeding), i.e. compared with 240 
the ad libitum control, and was significantly increased after 6, 24, and 48 h of refeeding in 241 
comparison with the 0 h group (P < 0.01). Moreover, a significant positive correlation between 242 
nNOS protein level and mucosal height was apparent during the 48-h refeeding period (r = 0.725, P 243 
< 0.01). In contrast, iNOS protein was localized almost exclusively in the mucosal epithelial 244 
monolayer (Figure 1), and its expression increased following fasting (0 h refeeding) and was 245 
markedly reduced at each refeeding time point (P < 0.01, Table 1). We identified a significant 246 
negative correlation between iNOS protein expression and mucosal height during the 48 h of 247 
refeeding (r = -0.898, P < 0.01). In addition, there was a significant negative correlation between 248 
jejunal levels of nNOS and iNOS proteins over this same period (r = -0.734, P < 0.01). 249 
Intestinal nNOS and iNOS mRNA expression 250 
The expression of nNOS mRNA in jejunal tissues gradually increased in a 251 
refeeding-time-dependent manner (Figure 2), being significantly higher at the 24- and 48-h time 252 
points (P < 0.05 and P < 0.01, respectively, vs. 0 h). However, iNOS mRNA expression showed the 253 
opposite trend, decreasing as refeeding time increased, with significantly reduced levels after 24 and 254 
48 h of refeeding (both P < 0.01 vs. 0 h). 255 
NO, reactive oxygen species (ROS), and IFN-γ as apoptosis mediators 256 
Since we previously determined that fasting causes jejunal apoptosis via ROS production and 257 
subsequent induction of IFN-γ transcription following increased iNOS expression,9 in the present 258 
work, we measured levels of nitrite (indicating NO production), 8-OHdG (as a marker of ROS 259 
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presence), and IFN-γ mRNA (a ROS-mediated iNOS inducer). Consistent with the abovementioned 260 
changes in iNOS transcription and translation, fasting increased intestinal nitrite levels (P < 0.01, 0 h 261 
vs. ad libitum), which were significantly reduced after refeeding (P < 0.01, Figure 3). Furthermore, 262 
the elevated jejunal 8-OHdG levels observed after fasting were substantially diminished by 24 and 263 
48 h of refeeding (P < 0.05 vs. 0 h, Figure 4). Transcription of IFN-γ, which increased as a result of 264 
fasting (P < 0.01), also significantly fell following refeeding (P < 0.01, Figure 5). These results 265 
mirrored the alterations observed in intestinal iNOS expression, suggesting that iNOS is regulated at 266 
the transcriptional level during fasting and refeeding through signalling mediators including ROS 267 
and IFN-γ. 268 
Evaluation of enterocyte apoptosis in the jejunal mucosae of fasted and refed rats 269 
Table 2 shows AIs for the villi and crypts of rats in each treatment group. Using histomorphometric 270 
assessment of jejunal cells, we evaluated the contribution of reduced apoptosis to recovery from 271 
fasting-induced mucosal atrophy following refeeding. The heightened villus AI recorded after 72 h of 272 
fasting (0 h refeeding) decreased at each refeeding time point, with a significant difference (P < 0.01) 273 
in jejunal AI evident between the 0 and 48 h groups. AI distribution profiles (Figure 6A) determined 274 
by histomorphometry, which is preferable to TUNEL for quantitative assessment, showed increased 275 
apoptosis along the entire jejunal villus after fasting, with the lower half of this structure (cell 276 
positions 1 to 40) being predominantly affected at 0 h, before AIs at this location began to reduce due 277 
to refeeding. After 72 h of fasting, the AI observed in jejunal crypts was elevated, and significantly 278 
decreased at the 6- and 48-h refeeding time points (P < 0.01, Table 2). From the AI distribution 279 
profiles, increased apoptosis in the lower thirds of crypts (cell positions 1 to 10) was evident after 280 
fasting (Figure 6B), which diminished following refeeding. Notably, the increased apoptosis 281 
observed after fasting conspicuously decreased after 6-h refeeding, but slightly increased after 24- 282 
and 48-h refeeding, compared with the 6-h time point. These changes might be a cell response to the 283 
transition from fasting to feeding. This result was broadly consistent with changes in intestinal iNOS 284 
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levels, indicating that enterocyte apoptosis may be regulated by iNOS expression during fasting and 285 
refeeding. 286 
Evaluation of cell proliferation in the jejunal crypts of fasted and refed rats 287 
To evaluate the importance of reduced cell proliferation in jejunal mucosal atrophy, we assessed 288 
5-BrdU incorporation, a proliferation indicator, in the jejunum. Although cell proliferation decreased 289 
after 72 h of fasting (0 h refeeding) compared with the ad libitum feeding control, it rose 290 
significantly after 24 and 48 h of refeeding in comparison to the 0 h group (P < 0.05, Figure 7).  291 
Jejunal MI 292 
Figure 8 shows the effect of fasting and refeeding on jejunal motility. The MI decreased during the 293 
second and third days of fasting compared with the ad libitum feeding period, and was greatly 294 
depressed between approximately 4:00 a.m. and 12:00 noon in particular. By the second day of 295 
refeeding after fasting for 3 days, the MI was higher than during the fasting period, and from 4:00 296 
a.m. to 12:00 noon, had increased to nearly the level observed with ad libitum feeding. Decreased 297 
jejunal motility caused by fasting was restored after refeeding, reflecting the pattern of nNOS 298 
expression in response to these same events. Thus, both crypt cell proliferation and the jejunal MI 299 
were consistent with intestinal expression of nNOS, the transcription of which may therefore be 300 
regulated according to the absence or presence of luminal mechanical stimuli affecting the jejunal 301 
mucosa during fasting and refeeding. 302 
 303 
Discussion 304 
We previously showed that fasting causes intestinal mucosal atrophy resulting from increased 305 
apoptosis in jejunal villi, ROS production, and IFN-γ transcription following elevated iNOS 306 
expression, and decreased cell proliferation in jejunal crypts.9 As these apoptosis mediators are all 307 
supressed by treatment with the iNOS inhibitor aminoguanidine, with consequent mucosal recovery, 308 
iNOS is likely to be a significant upstream factor promoting fasting-induced apoptosis in intestinal 309 
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epithelial cells. Furthermore, in contrast to the increase in iNOS transcription observed, we found 310 
that fasting decreased jejunal nNOS mRNA levels.  311 
A small number of previous studies have also evaluated the roles of iNOS and nNOS in the 312 
intestine. For instance, Masaoka et al. investigated the occurrence of nitrergic dysfunction and 313 
intestinal inflammation and dysmotility in normoglycaemic diabetes-prone animals,14 and Li et al. 314 
evaluated the role of these NOSs in IRI and AR following rat intestine transplantation, by 315 
administration of an NO inhibitor.15 In addition, Lu et al. assessed NOS functions and expression 316 
changes in neonatal rats subjected to lipopolysaccharide (LPS)-induced intestinal injury, describing 317 
an association between NEC and NOS levels in the mucosa.12 The results of these studies suggest 318 
that increased iNOS and decreased nNOS mRNA and protein levels contribute to each of the 319 
pathologies examined. Observations of the modulation of iNOS and nNOS expression are important 320 
when considering diseases of the small intestine or recovery from small intestinal injury. 321 
The absence of food passing through the gastrointestinal tract during fasting represents a 322 
physiological challenge evoking functional and morphological changes in response to the lack of 323 
luminal nutrients1,25-27 and mechanical stimuli, including peristalsis and villous motility.28-30 The 324 
function and morphology of the small intestinal epithelium is precisely maintained by apoptosis and 325 
cell proliferation.31-33 Previous reports have demonstrated that fasting-induced apoptosis and 326 
suppressed cell proliferation are principally regulated by luminal nutrition or mechanical 327 
stimuli.1,27,29 Based on these findings, and because refeeding following fasting ameliorates jejunal 328 
mucosal atrophy,26,34 we supposed that refeeding might rescue the apoptosis and suppressed cell 329 
proliferation resulting from lack of food, and that control of iNOS and nNOS expression may be 330 
associated with recovery from mucosal injury. 331 
Recently, Qu and colleagues demonstrated that nNOS, the predominant NOS isoform (>90%) in the 332 
rat small intestine, suppresses constitutive expression of iNOS under normal conditions through 333 
nuclear factor-kappa B (NF-κB) down-regulation. Moreover, nNOS inhibition leads to IκBα 334 
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degradation, followed by NF-κB activation and a subsequent increase in iNOS expression.35 Recent 335 
and accumulating evidence has revealed that under physiological conditions, NF-κB proteins are 336 
inhibited by S-nitrosylation of critical cysteine residues, perhaps due to constitutive production of 337 
NO by NOS.36 It is possible that intestinal nNOS suppression during fasting up-regulates NF-κB, 338 
leading to iNOS induction. nNOS activation during refeeding may then inhibit NF-κB, leading to 339 
iNOS suppression. Therefore, we hypothesized that iNOS activity is regulated by nNOS during 340 
recovery by refeeding from rat intestinal mucosal atrophy caused by fasting-induced apoptosis and 341 
suppressed cell proliferation. 342 
There have been few reports regarding the involvement of iNOS in fasting-induced intestinal 343 
mucosal atrophy, and even fewer concerning nNOS. More importantly, the roles of these enzymes in 344 
recovery from this condition by refeeding have not yet been described. The objective of the present 345 
study was to examine the effects of refeeding on intestinal mucosal recovery from fasting-induced 346 
apoptosis and suppressed cell proliferation, with a particular focus on the possible participation of 347 
intestinal nNOS and iNOS in this process.  348 
Here, we found that intestinal mucosal atrophy following fasting was remedied by refeeding, 349 
evident from increased mucosal height and accompanied by elevated nNOS and decreased iNOS 350 
protein levels, associated with reduced apoptosis (Table 1). iNOS and nNOS mRNA expression was 351 
consistent with this (Figure 2). We identified a negative correlation between iNOS and nNOS 352 
expression associated with recovery from mucosal atrophy. This is supported by the fact that nNOS 353 
is known to suppress iNOS transcription.35  354 
Although fasting caused increased production of NO, ROS, and IFN-γ as apoptosis mediators 355 
following elevation of iNOS expression,9 refeeding inhibited NO and ROS generation and IFN-γ 356 
induction, after decreasing iNOS levels (Figures 3 to 5). We used histomorphometric assessment of 357 
apoptotic changes in the jejunum to evaluate the importance of changes in apoptosis to intestinal 358 
recovery during refeeding. The raised AI recorded in villi and crypts after 72 h of fasting decreased 359 
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with refeeding (Table 2). In addition, AI distribution profiles generated to identify the location of 360 
apoptotic enterocytes showed increased apoptosis along the length of jejunal villi after fasting, with 361 
the lower halves of such structures being particularly affected before recovery following refeeding 362 
(Figure 6A). The lower third of crypt cells also exhibited heightened apoptosis after removal of food, 363 
which diminished with refeeding (Figure 6B).  364 
Boza et al. also tested the effect of refeeding on intestinal repair in fasted rats.26 As in the present 365 
study, refed rats were found to have lower levels of apoptosis in the small intestine than fasted 366 
controls. Kakimoto et al. investigated intestinal mucosal apoptosis in rats fasted and subsequently fed 367 
expanded polystyrene as an indigestible material.29 They observed a decrease in fasting-induced 368 
apoptosis due to the luminal mechanical stimulus provided by the presence of polystyrene in the 369 
intestine. Therefore, together with the present study, this suggests that luminal mechanical stimuli 370 
may mitigate increased intestinal apoptosis caused by fasting, and that intestinal iNOS activity might 371 
be regulated by nNOS in this process. 372 
The results of the current investigation also indicated that suppression of cell proliferation during 373 
fasting was restored by refeeding (Figure 7). With TPN, as in fasting, the gastrointestinal tract goes 374 
unused, resulting in mucosal atrophy. Xiao et al. demonstrated that oral glutamate supplementation 375 
prevents intestinal atrophy in a mouse model of TPN.27 TPN decreased proliferating cell nuclear 376 
antigen (PCNA) mRNA and protein expression, used as an indicator of cell proliferation in mucosal 377 
crypts, whereas oral administration of glutamate, making it the sole luminal nutrient, prevented 378 
PCNA down-regulation during TPN. However, cell proliferation in intestinal crypts appears to be 379 
controlled by not only luminal nutrients, but also mechanical stimuli. Chaturvedi et al. investigated 380 
whether Src and Rac1 mediate deformation-induced FAK and ERK phosphorylation and 381 
proliferation of intestinal epithelial cells.28 Repetitive deformation due to peristalsis and villous 382 
motility was found to promote such proliferation in vitro via a pathway involving these four 383 
molecules. Spencer et al. demonstrated that longitudinal mechanical stretching induces small 384 
17 
 
intestinal growth in vivo, while maintaining its function.30 The stretched bowel demonstrated a 385 
marked increase in crypt depth, accompanied by dramatically enhanced epithelial proliferation. 386 
Similar luminal mechanical stimuli resulting from refeeding induced proliferation of the intestinal 387 
epithelium, resulting in repair of mucosal atrophy. 388 
In the present work, we demonstrated that decreased jejunal motility following fasting was restored 389 
by refeeding (Figure 8). These changes were accompanied by a corresponding reduction and increase 390 
in nNOS expression during fasting and refeeding, respectively (Table 1, Figure 2). A number of 391 
articles have addressed nNOS expression in relation to intestinal motility. Sasselli et al. investigated 392 
the ability of embryonic stem (ES) cells to respond to environmental cues relayed by the enteric 393 
nervous system (ENS) and associated tissues.37 Expression of nNOS, regarded as a key molecule in 394 
the regulation of gastrointestinal motility, was observed to be induced in ES cells co-cultured with 395 
gut tissue comprising longitudinal muscle and adherent myenteric plexus. Furthermore, Grasa et al. 396 
established that down-regulation of nNOS is associated with rabbit intestinal dysmotility caused by 397 
local administration of LPS.38 Several reports have noted a decrease in nNOS expression in the 398 
absence of mechanical stimuli in the small intestinal lumen during fasting.9,39 The current work 399 
provides further support for the relationship between mechanical stimuli and nNOS. Nakao et al. 400 
investigated whether nNOS expression in the myenteric plexus is regulated by the vagus or 401 
splanchnic nerves of the rat small intestine,40 finding it to be independent of the former, but 402 
negatively regulated by the latter. The presence of an alimentary bolus in the gastrointestinal tract 403 
attenuates stimulation of the splanchnic nerves, and as a result, nNOS expression increases and 404 
jejunal motility may be promoted. We suggest that luminal mechanical stimulation caused by 405 
refeeding induces nNOS expression and subsequent jejunal motility. 406 
If this is the case, additional questions are raised regarding the mechanism by which changes in 407 
intestinal motility provoked by fasting or refeeding, in other words the absence or presence of 408 
luminal mechanical stimuli, affect nNOS activity. This remains unclear because very few studies 409 
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concerning these issues have been carried out. Under normal conditions, enterocyte apoptosis is 410 
confined to villi apices,41 whereas apoptotic cells in fasting rats are distributed throughout the whole 411 
intestine, being predominantly localized in the mucosa in close proximity to crypts and the myenteric 412 
plexus, where nNOS-containing neurons are abundant.42,43 In the present study, histomorphometric 413 
assessment suggested that the reduction in apoptosis observed during refeeding principally took 414 
place in the lower halves of villi and lower thirds of crypts, while cell proliferation appeared to 415 
increase in the crypts, where nNOS activity may be restored by refeeding (Figure 6A, 6B, 7). 416 
nNOS-positive neurons in the myenteric plexus receive sensory inputs from mucosal signals relayed 417 
by intrinsic primary afferent neurons (IPANs). IPANs are activated by the contents of the intestine, 418 
initiating peristalsis44 and transmitting NO and acetylcholine signals from the myenteric plexus to 419 
mainly circular muscles through inhibitory and excitatory motor pathways projecting anally and 420 
orally, respectively.45 Although nNOS-positive motor neurons are yet to be identified in the mucosa 421 
and submucosa, the terminals of nerves originating in the myenteric plexus have been observed 422 
scattered in these intestinal layers.46 Some of these nerves are linked to the submucosal plexus, 423 
involved in secretomotor and vasomotor reflexes through vasoactive intestinal polypeptide (VIP) and 424 
VIP-mediated NO signalling,47-49 suggesting that mucosal secretion and vasodilation following 425 
feeding might be at least partially controlled by nitrergic neurons of the ENS.  426 
As these reflexes are activated by mechanical stimuli acting on the bowel mucosa during feeding, 427 
intestinal motility provoked by fasting or refeeding might affect nNOS activity. This is supported by 428 
the findings of the present study, which implied that luminal mechanical stimulation caused by 429 
refeeding after fasting induced nNOS expression and subsequently, jejunal motility. 430 
In conclusion, the present study showed that refeeding rescues intestinal nNOS activity by luminal 431 
mechanical stimulation of the lumen, and potentially restores mucosal homeostasis by suppressing 432 
iNOS-induced apoptosis and increasing nNOS-induced cell proliferation.  433 
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Legends 557 
Figure 1 iNOS and nNOS protein expression in the jejuna of fasted and refed rats. Light 558 
micrographs of immunohistochemical staining for iNOS and nNOS. Ad libitum: control rats with free 559 
access to food; 0 h, 6 h, 24 h, and 48 h represent the length of time for which rats were refed after 72 560 
h of fasting. Seven rats were included in each group. Magnification: 40× (iNOS); 100× (nNOS). 561 
Figure 2 iNOS and nNOS mRNA expression in the jejuna of fasted and refed rats. RT-PCR products 562 
were visualized by electrophoresis (upper panels), and the intensities of the resulting bands were 563 
measured (lower charts). iNOS and nNOS expression levels were normalized to those of GAPDH. 564 
Values are means ± SE. aP < 0.01 vs. ad libitum; bP < 0.05, cP < 0.01 vs. 0 h refed. Seven rats were 565 
included in each group. 566 
Figure 3 Nitrite levels in the jejuna of fasted and refed rats. HPLC was used to measure nitrite 567 
concentration as an indicator of NO production. Values are means ± SE. aP < 0.05, bP < 0.01 vs. ad 568 
libitum; cP < 0.01 vs. 0 h refed. Seven rats were included in each group. 569 
Figure 4 Levels of 8-OHdG in the jejuna of fasted and refed rats. ELISA was employed to assess the 570 
presence of 8-OHdG, a product of DNA oxidation and indicative of ROS production. Values are 571 
means ± SE. aP < 0.05 vs. ad libitum; bP < 0.05 vs. 0 h refed. Seven rats were included in each 572 
group. 573 
Figure 5 Expression of IFN-γ mRNA in the jejuna of fasted and refed rats. Data were collected and 574 
analysed as in Figure 2. Values are means ± SE. aP < 0.01 vs. ad libitum; bP < 0.05, cP < 0.01 vs. 0 h 575 
refed. Seven rats were included in each group. 576 
Figure 6 AI distribution profiles in the jejunal mucosae of fasted and refed rats. A: AI distribution 577 
profiles in the villus. B: AI distribution profiles in the crypt. AI was defined as the total number of 578 
apoptotic cells at each position expressed as a percentage of the total number of cells counted at that 579 
position. Position 1 was defined as the cell at the crypt-villus junction, and that at the base of the 580 
crypt for the villus and crypt data, respectively. Apoptosis was detected by histomorphometric 581 
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assessment of H&E-stained tissue specimens. Seven rats were included in each group. 582 
Figure 7 Cell proliferation indices of the jejunal crypts of fasted and refed rats. 583 
Immunohistochemical staining was used to count the number of 5-BrdU-positive cells. Values are 584 
means ± SE. aP < 0.05 vs. ad libitum; bP < 0.05 vs. 0 h refed. Seven rats were included in each 585 
group. 586 
Figure 8 Jejunal MIs of fasted and refed rats. A miniature strain gauge force transducer was 587 
surgically inserted into the abdomens of rats to record jejunal contractions. The MI is expressed as a 588 
proportion of the mean MI recorded during the 24-h ad libitum period. The results of one experiment, 589 
representative of the three experiments performed, are shown. 590 
Table 1 Evaluation of intestinal mucosal atrophy and nNOS and iNOS protein expression in fasted 591 
and refed rats. Mucosal height (villous height plus crypt depth) was measured by observing 592 
H&E-stained specimens. Protein levels were assessed based on average optical densities of 593 
immunohistochemically stained tissue sections. Ad libitum: control rats with free access to food; 0 h, 594 
6 h, 24 h, and 48 h represent the length of time for which rats were refed after 72 h of fasting. Values 595 
are means ± SE. aP < 0.01 vs. ad libitum; bP < 0.01 vs. 0 h refed. Seven rats were included in each 596 
group. 597 
Table 2 Enterocyte apoptosis in the jejunal mucosae of fasted and refed rats. Apoptosis was 598 
measured as in Figure 6. Values are means ± SE. aP < 0.05, bP < 0.01 vs. ad libitum; cP < 0.01 vs. 0 h 599 
refed. Seven rats were included in each group. 600 
  601 
26 
 
Statement of Author Contributions and Acknowledgments 602 
Author contributions: JI and HU contributed equally to this work. JI, HU, KO, and JK designed the 603 
study; JI, HU, NM, KO, and YS conducted the experiments; JI and HU wrote the paper; HU and JK 604 
revised the paper; HU supported this work. 605 
Acknowledgments: We would like to thank Editage (www.editage.jp) for English language editing. 606 
Table 1 
                
    
Ad libitum 
   Refed     
    0 h 6 h 24 h 48 h   
  Body weight (g) 239.4 ± 3.3  178.1 ± 2.4 a  199.3 ± 4.0 a, b  202.7 ± 5.5 a, b  205.3 ± 2.3 a, b   
  Jejunum             
  
    Mucosal height  
                  (µm) 
606.5 ± 8.5  437.9 ± 5.9 a  465.9 ± 8.6 a  471.2 ± 7.9 a, b  554.4 ± 5.7 a, b 
  
    iNOS protein 
    (optical density) 
0.128 ± 0.008  0.673 ± 0.023 a  0.426 ± 0.020 a, b  0.077 ± 0.017 b  0.042 ± 0.003 a, b 
  
    nNOS protein 
    (optical density) 
0.078 ± 0.003  0.053 ± 0.002 a  0.086 ± 0.003 b  0.092 ± 0.003 a, b  0.095 ± 0.002 a, b 
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Table 2 
                
    
Ad libitum 
   Refed     
0 h 6 h 24 h 48 h       
  Villus             
     Cells per villus column, n      88 ± 2     65 ± 1 b     70 ± 1 b     70 ± 1 b     77 ± 1 b, c   
  
   Apoptotic cells  
          per villus column, n 
   0.05 ± 0.01   0.32 ± 0.03 b   0.29 ± 0.03 b   0.25 ± 0.03 b   0.13 ± 0.04 c   
     Apoptotic index (%)    0.06 ± 0.01   0.49 ± 0.05 b   0.42 ± 0.05 b   0.35 ± 0.05 b   0.17 ± 0.05 c   
Crypt 
   Cells per crypt column, n      28 ± 0.1      22 ± 0.1 b     22 ± 0.3 b     23 ± 0.1 b     25 ± 0.3 b, c 
   Apoptotic cells  
          per crypt column, n 
   0.07 ± 0.00    0.18 ± 0.02 b   0.05 ± 0.01 c   0.13 ± 0.02 a   0.10 ± 0.01 c 
   Apoptotic index (%)    0.25 ± 0.01    0.81 ± 0.08 b   0.25 ± 0.07 c   0.56 ± 0.07 b   0.41 ± 0.05 c 
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